From August 14, 2023 to September 30, 2023, the company has repurchased 9,829 shares, representing 0.008185% for CNY 0.53 million. With this, the company has completed the repurchase of 9,829 shares, representing 0.008185% for CNY 0.53 million under the buyback announced on August 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
55.23 CNY | +0.24% | +0.73% | -13.41% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.41% | 907M | |
+45.81% | 754B | |
+41.23% | 630B | |
-5.77% | 352B | |
+20.16% | 331B | |
+9.41% | 298B | |
+18.83% | 250B | |
+12.08% | 217B | |
-0.57% | 216B | |
+6.66% | 164B |
- Stock Market
- Equities
- 688513 Stock
- News Chengdu Easton Biopharmaceuticals Co., Ltd.
- Tranche Update on Chengdu Easton Biopharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on August 14, 2023.